Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-30 @ 1:14 AM
Study NCT ID:
NCT07483905
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-19
First Post:
2026-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Interest in Nighttime Day Hospital Chemotherapy Infusions Among Gynecologic Cancer Patients
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Study Overview
Official Title:
Assessment of Interest Among Patients With Gynecologic Cancers in a Nighttime Day Hospital (DH) Service for Long-duration Chemotherapy Infusions: an Observational Study Based on an Anonymous Online Survey.
Status:
NOT_YET_RECRUITING
Status Verified Date:
2026-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CHeMoON
Brief Summary:
This observational study aims to assess the interest of patients with gynecologic cancers in a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions. An anonymous online survey will be distributed to eligible patients to evaluate their preferences, perceived benefits, and potential barriers related to receiving chemotherapy during nighttime hours. The results of this study will help inform the feasibility and acceptability of implementing a nighttime Day Hospital service for prolonged chemotherapy infusions.
Detailed Description:
Long-duration chemotherapy infusions are increasingly used in the treatment of gynecologic cancers. These treatments often require prolonged administration times that may extend over several hours and may affect patients' daily activities and quality of life when delivered during standard daytime hospital schedules. The implementation of a nighttime Day Hospital service for the administration of long-duration chemotherapy infusions could represent an alternative organizational model aimed at improving patient convenience and optimizing hospital resource utilization. However, the acceptability of such a service from the patients' perspective has not been well explored.
This observational study will evaluate the interest and perceived acceptability of a nighttime Day Hospital service among patients with gynecologic cancers who may receive long-duration chemotherapy infusions. Data will be collected through an anonymous online survey administered to eligible patients. The questionnaire will explore patient preferences, potential advantages and disadvantages, logistical considerations, and willingness to receive chemotherapy during nighttime hours.
The results of this study may provide preliminary information on patient perspectives and help inform future organizational strategies for the delivery of prolonged chemotherapy infusions.
This observational study will evaluate the interest and perceived acceptability of a nighttime Day Hospital service among patients with gynecologic cancers who may receive long-duration chemotherapy infusions. Data will be collected through an anonymous online survey administered to eligible patients. The questionnaire will explore patient preferences, potential advantages and disadvantages, logistical considerations, and willingness to receive chemotherapy during nighttime hours.
The results of this study may provide preliminary information on patient perspectives and help inform future organizational strategies for the delivery of prolonged chemotherapy infusions.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| Study ID 26945 | OTHER | CET Lazio Area 3 | View |